"Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination" by Ronald M. Fairman

Article

Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination

Journal of Vascular Surgery (2002)

Ronald M. Fairman, University of Pennsylvania
Jeffrey P. Carpenter, University of Pennsylvania
Richard A. Baum, University of Pennsylvania
Robert A. Larson, University of Pennsylvania
Michael A. Golden, University of Pennsylvania
Clyde F. Barker, University of Pennsylvania
Marc E. Mitchell, University of Pennsylvania
Omaida C. Velazquez, University of Pennsylvania

Link

Disciplines

Publication Date

January 4, 2002

DOI

10.1067/mva.2002.121570

Citation Information

Ronald M. Fairman, Jeffrey P. Carpenter, Richard A. Baum, Robert A. Larson, et al.. "Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination" Journal of Vascular Surgery Vol. 35 Iss. 4 (2002) p. 679 - 685
Available at: http://works.bepress.com/jeffrey-p-carpenter/136/